MSRPS
MYGN icon

Maryland State Retirement & Pension System’s Myriad Genetics MYGN Stock Holding History

Maryland State Retirement & Pension System’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,415
Closed -$82.5K – 1388
2025
Q4 		$82.5K Hold
13,415
– – ﹤0.01% 1357
2025
Q3 		$97K Sell
13,415
-13,508
-50% -$80.2K ﹤0.01% 1353
2025
Q2 		$143K Buy
26,923
+436
+2% +$2.58K ﹤0.01% 1469
2025
Q1 		$235K Sell
26,487
-4,182
-14% -$50.2K 0.01% 1347
2024
Q4 		$420K Hold
30,669
– – 0.01% 1178
2024
Q3 		$840K Sell
30,669
-888
-3% -$24K 0.02% 763
2024
Q2 		$772K Sell
31,557
-346
-1% -$7.59K 0.01% 847
2024
Q1 		$597K Sell
31,903
-323
-1% -$6.94K 0.01% 997
2023
Q4 		$617K Buy
32,226
+2,066
+7% +$35.7K 0.01% 987
2023
Q3 		$484K Sell
30,160
-1,614
-5% -$30.7K 0.01% 1080
2023
Q2 		$737K Sell
31,774
-859
-3% -$18.7K 0.02% 817
2023
Q1 		$758K Sell
32,633
-528
-2% -$10.7K 0.02% 767
2022
Q4 		$481K Buy
+33,161
New +$618K 0.01% 1019
2022
Q3 		– Sell
-32,660
Closed -$593K – 917
2022
Q2 		$593K Buy
32,660
+638
+2% +$13.2K 0.02% 822
2022
Q1 		$807K Buy
32,022
+187
+0.6% +$4.79K 0.02% 722
2021
Q4 		$879K Buy
31,835
+1,264
+4% +$36.6K 0.02% 720
2021
Q3 		$1.01M Buy
+30,571
New +$1.02M 0.03% 613

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Maryland State Retirement & Pension System's MYGN Position: Q1 2026 in Review

Maryland State Retirement & Pension System sold out of Myriad Genetics (MYGN) in Q1 2026, closing a stake of 13,415 shares — an estimated $82.5K sold.

Maryland State Retirement & Pension System first reported a position in MYGN in Q3 2021 and held it in 17 quarters. The position peaked at $1.01M in Q3 2021. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Maryland State Retirement & Pension System reported no remaining Myriad Genetics position as of Q1 2026 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 13,415 Myriad Genetics shares in Q1 2026, an estimated $82.5K.
  • Maryland State Retirement & Pension System first reported a position in Myriad Genetics in Q3 2021 and held it in 17 quarters.
  • Maryland State Retirement & Pension System's Myriad Genetics position peaked at $1.01M in Q3 2021.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2026, filed 4 May 2026.